Demographic and behavioral contextual risk groups among men who have sex with men participating in a phase 3 HIV vaccine efficacy trial
Article Abstract:
A study used Baseline demographic, sexual partnership and substance use information to identify contextual-risk groups among 5,095 HIV-seronegative MSM enrolled in a 36-month phase 3 HIV vaccine efficacy trials across 61 sites primarily in North America. It is seen that differences in HIV incidence, study compliance and retention observed among contextual-risk groups indicate that responsiveness to heterogeneity within risk group could benefit screening, enrollment and retention of HIV-prevention programs and intervention trials, thereby reducing the time and cost related to their design, implementation and conclusion.
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
Risk reduction counseling is associated with decreased HIV transmission-associated behaviors in high-risk Indian heterosexuals
Article Abstract:
A study was conducted to estimate the incidence of HIV and impact of risk-reduction counseling (RRC) in a cohort of people with high-risk behavior for HIV transmission in Chennai, India. Results reveal that the individualized sexual RRC seems to be a useful intervention to reduce risk-taking behavior among at-risk hetero-sexuals in India.
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
Recruitment and baseline epidemiologic profile in the first phase 3HIV vaccine efficacy trial
Article Abstract:
The recruitment and baseline epidemiologic characteristics of volunteers in the first phase 3 placebo-controlled trial of a recombinant gp 120HIV vaccine is described. The men and women at high risk for sexually transmitted HIV infection were successfully recruited for the first phase 3 HIV vaccine efficacy trial.
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Importance of sex partner HIV status in HIV risk assessment among men who have sex with men. Update on syphilis: resurgence of an old problem
- Abstracts: Adherence to antiretroviral medication among HIV-positive patients in Thailand. Safety and antiretroviral effectiveness of concomitant use of rifampicin and efavirenz for antiretroviral-naive patients in India who are co infected with tuberculosis and HIV-1
- Abstracts: Awareness and prevention error in clinical decision-making. Learning how to communicate better with deafened patients
- Abstracts: Personality type and clinical evaluations in an obstetrics/gynecology medical student clerkship. Evaluating medical student obstetrics and gynecology clerkship performance: Which assessment tools are most reliable?
- Abstracts: Designing a simple help card for use with a syringe driver. Increasing awareness of a rare form of haematological cancer